Earnings History Data for Sigilon Therapeutics, Inc. (SGTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Sigilon Therapeutics, Inc.
Sigilon Therapeutics Inc. is a biotechnology company. It seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics(TM) platform. The company's product candidates consist of novel human cells engineered to produce the crucial proteins, enzymes or factors needed by patients living with chronic diseases such as hemophilia, diabetes and lysosomal storage disorders. Sigilon Therapeutics Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-11-2022 | PM | SGTX | Sigilon Therapeutics, Inc. | 17.28 | -0.27 | -0.43 | -0.63 | Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15, revenue of $4.25M beats by $1.75M [11/10/2022 9:18 AM] |
0.5250 | 0.05 (11.39%) |
0.0 | 0.0 (0.00%) |
0.43 - 5.31 | 8,510 | 20,000 | 0 | ||
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
SGTX | Sigilon Therapeutics | 24.00 | -0.44 | -0.46 | 0.00 | Sigilon Therapeutics GAAP EPS of -$0.44, revenue of $2.88M [8/4/2022 5:40 PM] |
0.8585 | 0.02 (2.41%) |
0.85 | 0.01 (1.40%) |
0.68 - 6.91 | 44,624 | 40,000 | 200 | |
| 12-05-2022 | AH | SGTX | Sigilon Therapeutics | 32.00 | -0.43 | -0.30 | 0.00 | Sigilon Therapeutics GAAP EPS of -$0.43, revenue of $3.17M [5/12/2022 5:02 PM] |
0.7784 | -0.03 (-3.92%) |
0.85 | 0.04 (4.93%) |
0.76 - 14.30 | 64,344 | 60,000 | 171 | ||
| 14-03-2022 | AH | SGTX | Sigilon Therapeutics | 44.00 | -0.55 | -0.46 | 0.00 | Sigilon Therapeutics GAAP EPS of -$0.55, revenue of $1.99M [3/14/2022 5:45 PM] |
1.38 | 0.07 (5.34%) |
1.40 | 0.11 (8.52%) |
1.20 - 30.10 | 9,588 | 112,805 | 202 | ||
|
||||||||||||||||||
| 10-11-2021 | AH | SGTX | Sigilon Therapeutics, Inc. | 170.54 | -0.63 | -0.69 | 0.00 | Sigilon Therapeutics EPS beats by $0.03, misses on revenue [11/10/2021 5:06 PM] |
4.97 | -0.02 (-0.40%) |
4.98 | -0.01 (-0.20%) |
4.33 - 54.32 | 53,635 | 100,000 | 142 | ||
| 10-08-2021 | PM | Before the open (Aug 10) |
SGTX | Sigilon Therapeutics, Inc. | 161.43 | -0.65 | -0.57 | 0.00 | Sigilon Therapeutics EPS misses by $0.02, misses on revenue [8/10/2021 8:36 AM] |
5.47 | 0.47 (9.40%) |
4.98 | -0.02 (-0.40%) |
4.81 - 54.32 | 421,284 | 210,000 | 213 | |
| 10-05-2021 | AH | 4:05 PM ET (May 10) |
SGTX | Sigilon Therapeutics, Inc. | 412.00 | -0.60 | -0.56 | 0.00 | Sigilon Therapeutics EPS misses by $0.01, misses on revenue [5/10/2021 4:51 PM] |
13.82 | 0.90 (6.97%) |
0.0 | 0.0 (0.00%) |
12.34 - 54.32 | 52,752 | 80,000 | 0 | |